Login / Signup

Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project).

Steffen Flindt NielsenCamilla Lundgreen DuusNiels Henrik BuusJesper Nørgaard BechFrank Holden Mose
Published in: JMIR research protocols (2024)
DERR1-10.2196/56067.
Keyphrases
  • chronic kidney disease
  • end stage renal disease
  • randomized controlled trial
  • type diabetes
  • quality improvement
  • glycemic control
  • peritoneal dialysis
  • open label
  • insulin resistance
  • systematic review
  • adipose tissue